Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04441567 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Right-Size Clinic Visits Using Memora Platform for PROMIS

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years 7 months later Oct 2026 → Jun 2029
See other at-risk trials from Boston Medical Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Oct 2026 to Jun 2029
  2. Minor Primary and study completion dates: Sep 2026 to Oct 2026
    • Eligibility criteria expanded, about 19 words
    • Secondary endpoints: details revised at 2 of 2 entries
    • Site contact updated
  3. Notable Primary and study completion dates: Sep 2025 to Sep 2026v12
  4. Minor Primary and study completion dates: Jun 2025 to Sep 2025v11
  5. Minor Re-verified, no change to tracked fieldsv10
Show 8 earlier versionsHide 8 earlier versions
  1. Notable Primary and study completion dates: Jun 2023 to Jun 2025v9
  2. Minor Re-verified, no change to tracked fieldsv8
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 2021 to May 10, 2021
    • Site details revised
    v7
  4. Minor Start date: Mar 2021 to Apr 2021v6
  5. Notable Primary and study completion dates: Jan 2022 to Jun 2023
    • Start date: Dec 2020 to Mar 2021
    v5
  6. Notable Start date: Oct 2020 to Dec 2020v4
  7. Notable Start date: Jul 2020 to Oct 2020v3
  8. Minor Study description shortened, about 4 wordsv2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Developing novel methods of patient communication is crucial in providing value-based care to orthopedic patients. Healthcare technology platforms have been developed to improve patient communication methods particularly for the administration of patient-reported outcome measures (PROMs). However, the majority of these interventions rely on web-based platforms that require patients to have computer access. Among American households earning less than $30,000 per year, only 59% have access to a desktop or laptop and just 47% have broadband internet at home compared to mobile phone penetration which is estimated at 95% of which 93% regularly use text messages. The use of phone messaging may be the most effective means to have patients complete PROMs. The Patient-Reported Outcomes Measurement Information System (PROMIS) is an NIH-funded, clinically validated method of tracking patient-reported outcomes to efficiently assess patient health status. PROMIS utilizes Item Response Theory (IRT) and computerized adaptive testing (CAT) to improve measurement precision and decrease survey time as compared to traditional PROMs. The purpose of this two-phase study is to utilize Memora Health's text-messaging platform to collect web-based PROMIS CAT surveys from patients (Phase 1) and use this information to right-size clinic visits (Phase 2).
Trial Details
NCT Number NCT04441567
Lead Sponsor Boston Medical Center
Conditions
(from sponsor)
Orthopedic Disorders
Related terms Musculoskeletal Diseases
Enrollment 3,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov